Levenson J, Chau N P, Billaud E, Simon A
Unité de Recherches Biomathématiques et Biostatistiques, Institut National de la Santé et de la Recherche Medicale U263 (INSERM U263), Paris, France.
Am J Cardiol. 1988 May 1;61(13):1056-60. doi: 10.1016/0002-9149(88)90125-7.
The simultaneous acute effects of converting enzyme inhibition by intravenous enalaprilat on the circulating renin-angiotensin system and on the brachial artery were studied in 12 hypertensive patients by a double-blind comparison with saline effects in 14 hypertensive patients. The brachial artery was investigated in terms of arterial section (measured by pulsed Doppler technique) and wall rigidity (assessed by pulse wave velocity). Arterial and biochemical parameters were measured in baseline before injection and at 20 to 40 minutes (t1) and 80 to 100 minutes (t2) after saline and drug injections. Compared with the saline vehicle, enalaprilat significantly decreased angiotensin enzyme converting activity (p less than 0.001), increased plasma renin activity (p less than 0.01) and decreased plasma aldosterone concentrations (p less than 0.01). The drug reduced blood pressure (p less than 0.01) and increased the brachial artery section (p less than 0.01), but did not change pulse wave velocity. In the enalaprilat group, significant postinjection relations were observed between: (1) enalaprilat concentration and plasma angiotensin converting enzyme activity (r = -0.72, p less than 0.001); (2) plasma renin activity and mean blood pressure (r = -0.46, p less than 0.02); (3) plasma enalaprilat concentration and pulse wave velocity (r = -0.50, p less than 0.01) and (4) pulse wave velocity and brachial artery section (r = 0.42, p less than 0.05). Thus, the brachial artery effects of enalaprilat were not directly related to the blockade of the renin-angiotensin system in plasma.(ABSTRACT TRUNCATED AT 250 WORDS)
通过对12例高血压患者静脉注射依那普利拉抑制转化酶的同时,与14例高血压患者注射生理盐水的效果进行双盲比较,研究了其对循环肾素-血管紧张素系统和肱动脉的急性影响。通过脉冲多普勒技术测量动脉截面积,并通过脉搏波速度评估血管壁硬度,以此对肱动脉进行研究。在注射生理盐水和药物前的基线状态以及注射后20至40分钟(t1)和80至100分钟(t2)测量动脉和生化参数。与生理盐水相比,依那普利拉显著降低了血管紧张素转化酶活性(p<0.001),增加了血浆肾素活性(p<0.01),并降低了血浆醛固酮浓度(p<0.01)。该药物降低了血压(p<0.01),增加了肱动脉截面积(p<0.01),但未改变脉搏波速度。在依那普利拉组中,观察到注射后存在显著的相关性:(1)依那普利拉浓度与血浆血管紧张素转化酶活性之间(r=-0.72,p<0.001);(2)血浆肾素活性与平均血压之间(r=-0.46,p<0.02);(3)血浆依那普利拉浓度与脉搏波速度之间(r=-0.50,p<0.01);(4)脉搏波速度与肱动脉截面积之间(r=0.42,p<0.05)。因此,依那普利拉对肱动脉的影响与血浆中肾素-血管紧张素系统的阻断并无直接关系。(摘要截断于250字)